Solaris Endovascular, Inc Press Releases - EIN Presswire

Published on January 8, 2026 - 21:15 GMT

Solaris Endovascular Announces Completion of Enrollment in DEScover Trial

Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical evidence of safety and performance. NEW ORLEANS, LA, UNITED STATES, January 8, 2026 /⁨EINPresswire.com⁩/ -- Solaris Endovascular, Inc., a …

Distribution channels: Aviation & Aerospace Industry, Banking, Finance & Investment Industry ...

Published on November 21, 2025 - 15:30 GMT

Solaris Endovascular Reports Positive 12-Month Results from the Solaris SX™ Iliac Multicenter Study

European real-world data show strong Solaris SX™ performance in PAD, complementing findings from the DEScover sirolimus-eluting program NEW YORK, NY, UNITED STATES, November 21, 2025 /⁨EINPresswire.com⁩/ -- Solaris Endovascular today announced encouraging …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 27, 2025 - 11:45 GMT

Solaris Endovascular Reports Positive Six-Month Interim Results for DEScover Trial

First Drug-Eluting Self-Expanding Covered Stent Demonstrates 95% Patency Through 6 Months; 100% Procedural Success and Zero 30-Day Device Related Adverse Events SAN FRANCISCO, CA, UNITED STATES, October 27, 2025 /⁨EINPresswire.com⁩/ -- Solaris …

Distribution channels: Amusement, Gaming & Casino, Aviation & Aerospace Industry ...

Published on September 2, 2025 - 20:00 GMT

Solaris Endovascular Exceeds Enrollment Milestone for DEScover Trial; Interim Data to be Shared at Vascular Conferences

80% of Patients Now Enrolled in Pioneering Drug-Eluting Covered Stent Graft Study NEW ORLEANS, LA, UNITED STATES, September 2, 2025 /⁨EINPresswire.com⁩/ -- Solaris Endovascular, Inc., a growth-stage U.S.-based medical device company specializing in …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 18, 2025 - 13:35 GMT

Solaris Endovascular, Inc. Surpasses Key Enrollment Milestone in DEScover Randomized Clinical Trial

42 Patients Enrolled in Pioneering Drug-Eluting Covered Stent Graft Study NEW ORLEANS, LA, UNITED STATES, February 19, 2025 /⁨EINPresswire.com⁩/ -- Solaris Endovascular, Inc., a leading US-based medical device company specializing in advanced endovascular …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 13, 2024 - 13:30 GMT

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

NEW ORLEANS, LA, UNITED STATES, November 13, 2024 /⁨EINPresswire.com⁩/ -- Solaris Endovascular, Inc. Launching to Address Vascular Health Challenges Globally Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...